While we demonstrate that Fancc-/-;Mad2+/- mice develop lethal AML and are predisposed to develop cancer earlier in life than both Fancc-/- and Mad2+/- mice, we also noted that all moribund Fancc-/-;Mad2+/- mice exhibited normal blood counts four weeks prior to death. This evidence concerns the gene FANCC and acute myeloid leukemia.